BofA Securities reiterated its Buy rating on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN), with a steady price target of GBP145.00. The firm's positive stance is based on the pharmaceutical giant's ...
Although these factors will affect Omron's free cash flow generation in fiscal 2024, we expect this to be temporary and the company's financial health to return to its normal state over the medium ...
Management will host an investor conference call and webcast today, Wednesday, February 12, 2025, at 8:30 a.m. Eastern Time to discuss the Company's first quarter fiscal year 2025 financial results, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback